JP2023548055A5 - - Google Patents
Info
- Publication number
- JP2023548055A5 JP2023548055A5 JP2023524708A JP2023524708A JP2023548055A5 JP 2023548055 A5 JP2023548055 A5 JP 2023548055A5 JP 2023524708 A JP2023524708 A JP 2023524708A JP 2023524708 A JP2023524708 A JP 2023524708A JP 2023548055 A5 JP2023548055 A5 JP 2023548055A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- compound according
- cancer
- compound
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063108645P | 2020-11-02 | 2020-11-02 | |
| US63/108,645 | 2020-11-02 | ||
| US202163166045P | 2021-03-25 | 2021-03-25 | |
| US63/166,045 | 2021-03-25 | ||
| US202163190067P | 2021-05-18 | 2021-05-18 | |
| US63/190,067 | 2021-05-18 | ||
| US202163218717P | 2021-07-06 | 2021-07-06 | |
| US63/218,717 | 2021-07-06 | ||
| US202163237782P | 2021-08-27 | 2021-08-27 | |
| US63/237,782 | 2021-08-27 | ||
| US202163244540P | 2021-09-15 | 2021-09-15 | |
| US63/244,540 | 2021-09-15 | ||
| PCT/US2021/057724 WO2022094464A1 (en) | 2020-11-02 | 2021-11-02 | Method of treating cancers with alkyne substituted quinazoline derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548055A JP2023548055A (ja) | 2023-11-15 |
| JP2023548055A5 true JP2023548055A5 (https=) | 2024-11-13 |
Family
ID=78819639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524708A Pending JP2023548055A (ja) | 2020-11-02 | 2021-11-02 | 癌をアルキン置換キナゾリン誘導体で治療する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240075042A1 (https=) |
| EP (1) | EP4236954A1 (https=) |
| JP (1) | JP2023548055A (https=) |
| KR (1) | KR20230093429A (https=) |
| AU (1) | AU2021368798A1 (https=) |
| CA (1) | CA3195473A1 (https=) |
| IL (1) | IL302329A (https=) |
| MX (1) | MX2023004998A (https=) |
| TW (1) | TWI910256B (https=) |
| WO (1) | WO2022094464A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020328598A1 (en) | 2019-08-15 | 2022-03-03 | Black Diamond Therapeutics, Inc. | Alkynyl quinazoline compounds |
| CA3231697A1 (en) * | 2021-09-21 | 2023-03-30 | Black Diamond Therapeutics, Inc. | Polymorphs as erbb inhibitors |
| WO2025038731A1 (en) * | 2023-08-15 | 2025-02-20 | Black Diamond Therapeutics, Inc. | Method of treating cancers with alkyne substituted quinazoline derivatives |
| WO2025128831A1 (en) * | 2023-12-13 | 2025-06-19 | Black Diamond Therapeutics, Inc. | Combinations comprising alkyne substituted quinazoline derivatives and their use in the treatment of cancer |
| WO2025137421A1 (en) * | 2023-12-21 | 2025-06-26 | Black Diamond Therapeutics, Inc. | Compositions comprising alkyne substituted quinazoline derivatives and related uses |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012122058A2 (en) * | 2011-03-04 | 2012-09-13 | Newgen Therapeutics, Inc. | Alkyne substituted quinazoline compound and methods of use |
| US20180193274A1 (en) * | 2014-12-24 | 2018-07-12 | Principia Biopharma Inc. | Compositions for ileo-jejunal drug delivery |
| JP2022502495A (ja) * | 2018-09-25 | 2022-01-11 | ブラック ダイアモンド セラピューティクス，インコーポレイティド | チロシンキナーゼ阻害剤としてのキナゾリン誘導体、組成物、それらの作製方法、およびそれらの使用 |
| AU2020328598A1 (en) * | 2019-08-15 | 2022-03-03 | Black Diamond Therapeutics, Inc. | Alkynyl quinazoline compounds |
-
2021
- 2021-11-02 US US18/034,749 patent/US20240075042A1/en active Pending
- 2021-11-02 MX MX2023004998A patent/MX2023004998A/es unknown
- 2021-11-02 KR KR1020237013278A patent/KR20230093429A/ko active Pending
- 2021-11-02 EP EP21816235.2A patent/EP4236954A1/en active Pending
- 2021-11-02 IL IL302329A patent/IL302329A/en unknown
- 2021-11-02 JP JP2023524708A patent/JP2023548055A/ja active Pending
- 2021-11-02 AU AU2021368798A patent/AU2021368798A1/en active Pending
- 2021-11-02 WO PCT/US2021/057724 patent/WO2022094464A1/en not_active Ceased
- 2021-11-02 CA CA3195473A patent/CA3195473A1/en active Pending
- 2021-11-02 TW TW110140833A patent/TWI910256B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023548055A5 (https=) | ||
| JP2021098728A5 (https=) | ||
| JP2022009090A5 (https=) | ||
| JP2024133475A5 (https=) | ||
| JP2022121594A5 (https=) | ||
| JP2024133474A5 (https=) | ||
| JP2017031160A5 (https=) | ||
| JP2021512121A5 (https=) | ||
| JP2022191257A5 (https=) | ||
| CN112888458A (zh) | Cldn18的抗体和化疗药物的联合治疗 | |
| JP2021512149A5 (https=) | ||
| JP2015523397A5 (https=) | ||
| JP2012515184A5 (https=) | ||
| JP2017505321A5 (https=) | ||
| JP2011529968A5 (https=) | ||
| JP2023523569A5 (https=) | ||
| FI3463345T3 (fi) | Farmaseuttisia yhdistelmiä | |
| JP2024502446A5 (https=) | ||
| JP2021535147A5 (https=) | ||
| JP2023116697A5 (https=) | ||
| JP2024524461A5 (https=) | ||
| JP2014144962A5 (https=) | ||
| EP4494701A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| JP2013544892A5 (https=) | ||
| JP2023102787A5 (https=) |